ES2266499T3 - Doxiciclina para el tratamiento del acne. - Google Patents

Doxiciclina para el tratamiento del acne. Download PDF

Info

Publication number
ES2266499T3
ES2266499T3 ES02731267T ES02731267T ES2266499T3 ES 2266499 T3 ES2266499 T3 ES 2266499T3 ES 02731267 T ES02731267 T ES 02731267T ES 02731267 T ES02731267 T ES 02731267T ES 2266499 T3 ES2266499 T3 ES 2266499T3
Authority
ES
Spain
Prior art keywords
acne
administered
use according
amount
tetracycline compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES02731267T
Other languages
English (en)
Spanish (es)
Inventor
Robert A. Ashley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Collagenex Pharmaceuticals Inc
Original Assignee
Collagenex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23079310&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2266499(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Collagenex Pharmaceuticals Inc filed Critical Collagenex Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2266499T3 publication Critical patent/ES2266499T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES02731267T 2001-04-05 2002-04-05 Doxiciclina para el tratamiento del acne. Expired - Lifetime ES2266499T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28191601P 2001-04-05 2001-04-05
US281916P 2001-04-05

Publications (1)

Publication Number Publication Date
ES2266499T3 true ES2266499T3 (es) 2007-03-01

Family

ID=23079310

Family Applications (1)

Application Number Title Priority Date Filing Date
ES02731267T Expired - Lifetime ES2266499T3 (es) 2001-04-05 2002-04-05 Doxiciclina para el tratamiento del acne.

Country Status (12)

Country Link
EP (4) EP1716856A3 (enExample)
JP (3) JP2004536046A (enExample)
KR (1) KR100926326B1 (enExample)
AT (1) ATE330615T1 (enExample)
AU (1) AU2002303250B2 (enExample)
CA (2) CA2440472C (enExample)
DE (1) DE60212613T2 (enExample)
DK (1) DK1383508T3 (enExample)
ES (1) ES2266499T3 (enExample)
NZ (1) NZ528197A (enExample)
PT (1) PT1383508E (enExample)
WO (1) WO2002080932A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2311796A1 (en) * 2002-01-08 2011-04-20 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
US8192749B2 (en) 2003-04-16 2012-06-05 Galderma Laboratories Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
WO2003088906A2 (en) * 2002-04-16 2003-10-30 Collagenex Pharmaceuticals, Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
WO2004091483A2 (en) 2003-04-07 2004-10-28 Shire Laboratories, Inc. Once daily formulations of tetracyclines
WO2005011707A1 (en) 2003-07-25 2005-02-10 Warner Chilcott Company, Inc. A doxycycline metal complex in a solid dosage form
WO2005046618A2 (en) * 2003-11-06 2005-05-26 Research Foundation Of State University Of New York, The Methods of treating eczema
US7541347B2 (en) 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US7544373B2 (en) 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US7704959B2 (en) * 2006-10-03 2010-04-27 Dow Pharmaceutical Sciences Azithromycin for the treatment of nodular acne
JP5395052B2 (ja) * 2007-03-23 2014-01-22 モレキュラー リサーチ センター インコーポレイテッド 炎症を処置するための組成物および方法
WO2008121107A1 (en) * 2007-04-02 2008-10-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
AU2009248046B2 (en) * 2008-05-16 2014-07-17 Galderma Research & Development Therapy regimen for treating acne related diseases
WO2010017310A1 (en) 2008-08-06 2010-02-11 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
JP2015516971A (ja) * 2012-04-19 2015-06-18 ガルデルマ エス．アー． ざ瘡の処置方法
RU2557991C1 (ru) * 2014-05-19 2015-07-27 Вячеслав Владимирович Чеботарёв Способ лечения больных вульгарными угрями (акне), страдающих дисплазией соединительной ткани
CO2017001953A1 (es) * 2017-02-27 2018-08-31 Corporacion Univ Lasallista Método de encapsulación de tetraciclinas
JP2020527607A (ja) * 2017-07-21 2020-09-10 アルミラール・リミテッド・ライアビリティ・カンパニーＡｌｍｉｒａｌｌ， Ｌｌｃ 非炎症性病変の処置
BR112020013789A2 (pt) * 2018-01-07 2021-02-17 Dr. Reddy's Laboratories Ltd. métodos para o tratamento de afecções cutâneas inflamatórias
US12208123B2 (en) 2019-01-04 2025-01-28 Dermata Therapeutics, Inc. Compositions and methods for the treatment of skin conditions
WO2021215405A1 (ja) * 2020-04-20 2021-10-28 国立大学法人大阪大学 免疫賦活化剤、及び治療又は予防用組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983000628A1 (en) * 1981-08-27 1983-03-03 Bernstein, Joel, E. A method of treating acne vulgaris and composition containing carbamide peroxide
US5122519A (en) * 1989-06-27 1992-06-16 American Cyanamid Company Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
ATE194492T1 (de) * 1990-08-16 2000-07-15 Bloom Leonard Topische behandlung von blepharitis
US5674539A (en) * 1994-12-09 1997-10-07 Tomas; Robert E. Method of treating skin and composition
FR2730930B1 (fr) * 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
US5827840A (en) * 1996-08-01 1998-10-27 The Research Foundation Of State University Of New York Promotion of wound healing by chemically-modified tetracyclines
US5789395A (en) * 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US5908838A (en) * 1998-02-19 1999-06-01 Medics Pharmaceutical Corporation Method for the treatment of acne
US6432934B1 (en) * 1998-08-06 2002-08-13 Advanced Vision Research Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease
US6015804A (en) * 1998-09-11 2000-01-18 The Research Foundation Of State University Of New York Method of using tetracycline compounds to enhance interleukin-10 production
CA2343038A1 (en) * 1998-09-28 2000-04-06 Maria Emanuel Ryan A novel inhibitor of cataract formation
US5998390A (en) * 1998-09-28 1999-12-07 The Research Foundation Of State University Of New York Combination of bisphosphonate and tetracycline
WO2000028983A1 (en) * 1998-11-18 2000-05-25 Collagenex Pharmaceuticals, Inc. Novel 4-dedimethy laminotetra cycline derivatives
JP2001072660A (ja) * 1999-09-08 2001-03-21 Welfide Corp ＴＮＦ−α産生抑制剤および／またはＩＬ−１０産生促進剤

Also Published As

Publication number Publication date
CA2440472A1 (en) 2002-10-17
EP1383508A1 (en) 2004-01-28
CA2719162A1 (en) 2002-10-17
PT1383508E (pt) 2006-11-30
DK1383508T3 (da) 2006-12-27
JP2004536046A (ja) 2004-12-02
DE60212613T2 (de) 2007-05-24
EP1716856A3 (en) 2009-02-18
AU2002303250B2 (en) 2006-05-25
ATE330615T1 (de) 2006-07-15
EP1383508A4 (en) 2005-07-06
JP2010053155A (ja) 2010-03-11
CA2440472C (en) 2011-01-18
JP2011168613A (ja) 2011-09-01
KR20040007488A (ko) 2004-01-24
EP1712236A3 (en) 2008-05-28
DE60212613D1 (de) 2006-08-03
EP1712236A2 (en) 2006-10-18
KR100926326B1 (ko) 2009-11-12
EP1383508B1 (en) 2006-06-21
CA2719162C (en) 2014-12-23
NZ528197A (en) 2007-04-27
EP1716856A2 (en) 2006-11-02
WO2002080932A1 (en) 2002-10-17
EP2221056A1 (en) 2010-08-25

Similar Documents

Publication Publication Date Title
ES2266499T3 (es) Doxiciclina para el tratamiento del acne.
US10058564B2 (en) Methods of treating acne
AU2002303250A1 (en) Methods of treating acne
US12161719B2 (en) Method of enhancing the antimicrobial action of systemically administered antibiotics
Javed et al. Local delivery of minocycline hydrochloride: a therapeutic paradigm in periodontal diseases
AU2025202935A1 (en) Composition and method for prevention and treatment of cutaneous radiation injury
AU2019354855B2 (en) Silicic acids for use in the treatment of periodontitis
Dusane et al. Recent trends in treatment of periodontitis
KR20040094833A (ko) 비-항균성 테트라사이클린 동족체의 용도 및 박테리아외독소의 치료를 위한 이의 제형
US20060252731A1 (en) Methods of treating recurrent aphthous stomatitis
EA046983B1 (ru) Кремниевая кислота для применения в лечении периодонтита
WO2007075269A2 (en) Method for inhibiting tooth displacement with non-antibacterial tetracyline formulations